Compare Rush Street Interactive Inc (RSI) vs Vertex Pharmaceuticals Incorporated (VRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rush Street Interactive Inc vs Vertex Pharmaceuticals Incorporated — how do they compare? Rush Street Interactive Inc trades at $25.14 (market cap $2.91B), while Vertex Pharmaceuticals Incorporated trades at $529.62 (market cap $134.25B). The key difference: Vertex Pharmaceuticals Incorporated is far larger — about 46.1× Rush Street Interactive Inc's market cap, and Vertex Pharmaceuticals Incorporated is trading nearer its 52-week high, Rush Street Interactive Inc nearer its low. Which is the better fit depends on your goals.
| RSI | VRTX | |
|---|---|---|
Market Cap | $2.91B | $134.25B |
Sector | Technology | Health |
52-Week High | $34.52 | $529.65 |
52-Week Low | $15.89 | $376.62 |
Enterprise Value | $2.57B | $128.37B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Rush Street Interactive (RSI) trades at $24.88, down 0.8% with strong technical momentum indicators showing oversold conditions (RSI at 16-17). The company reported record Q2 2026 revenue of $393.8 million, up 46% year-over-year, and raised full-year guidance. Analyst consensus remains strongly bullish with 10 buy ratings and a $34.75 price target representing 40% upside potential.
RSI demonstrates robust revenue growth and expanding market presence but faces valuation concerns with a high P/E of 80.26. Key risks include competitive pressures in online gambling and regulatory uncertainties. The combination of strong fundamentals, positive analyst sentiment, and oversold technical conditions suggests potential for near-term recovery.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Rush Street Interactive Inc
Rush Street Interactive, Inc. is a digital gaming and sports betting company operating in the regulated U.S. and international markets. The company owns and operates online casino (iGaming) and sports wagering platforms, including BetRivers and PlaySugarHouse brands. RSI focuses on providing a secure and high-quality online gaming experience, leveraging its proprietary technology platform and commitment to responsible gaming.
Read more on RSI →About Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Read more on VRTX →
